{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:09:50Z","timestamp":1789596590663,"version":"build-2803163510"},"reference-count":61,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Microsc Ultrastruct"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jmau.jmau_59_18","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:58:12Z","timestamp":1557385092000},"page":"103","source":"Crossref","is-referenced-by-count":26,"title":["Factors involved in relapse of multiple sclerosis"],"prefix":"10.4103","volume":"7","author":[{"given":"FatemahOmar","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2213-879X.257879-1","unstructured":"Wang C, Ruiz A, Mao-Draayer Y. Assessment and treatment strategies for a multiple sclerosis relapse. J Immunol Clin Res 2018;5. pii: 1032."},{"key":"key-10.4103\/2213-879X.257879-2","first-page":"907","volume-title":"Defining the clinical course of multiple sclerosis: Results of an international survey.National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"key-10.4103\/2213-879X.257879-3","first-page":"99","volume-title":"B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis","author":"Thompson","year":"2010","journal-title":"J Clin Immunol"},{"key":"key-10.4103\/2213-879X.257879-4","first-page":"2220","volume-title":"National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards","author":"Hachinski","year":"2006","journal-title":"Stroke"},{"key":"key-10.4103\/2213-879X.257879-5","first-page":"808","volume-title":"Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"key-10.4103\/2213-879X.257879-6","first-page":"292","volume-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2213-879X.257879-7","first-page":"1914","volume-title":"The natural history of multiple sclerosis: A geographically based study 10: Relapses and long-term disability","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"key-10.4103\/2213-879X.257879-8","first-page":"1511","volume-title":"Risk of relapse phenotype recurrence in multiple sclerosis","author":"Kalincik","year":"2014","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-9","first-page":"131","volume-title":"Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity","author":"Raimundo","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"key-10.4103\/2213-879X.257879-10","first-page":"662","volume-title":"Cost of multiple sclerosis in the Czech republic: The COMS study","author":"Blahova","year":"2012","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-11","first-page":"351416","volume-title":"The lived experience of multiple sclerosis relapse: How adults with multiple sclerosis processed their relapse experience and evaluated their need for postrelapse care","author":"Asano","year":"2015","journal-title":"Mult Scler Int"},{"key":"key-10.4103\/2213-879X.257879-12","first-page":"1414","volume-title":"Assessing changes in relapse rates in multiple sclerosis","author":"Inusah","year":"2010","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-13","first-page":"428","volume-title":"Will rogers phenomenon in multiple sclerosis","author":"Sormani","year":"2008","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2213-879X.257879-14","first-page":"1580","volume-title":"Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: Systematic review and meta-regression","author":"Steinvorth","year":"2013","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-15","first-page":"147","volume-title":"Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes","author":"Martinelli","year":"2014","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-16","first-page":"261","volume-title":"Lower serum Vitamin D levels are associated with a higher relapse risk in multiple sclerosis","author":"Runia","year":"2012","journal-title":"Neurology"},{"key":"key-10.4103\/2213-879X.257879-17","first-page":"140","volume-title":"Vitamin D: A candidate for the environmental effect in multiple sclerosis \u2013 Observations from Norway","author":"Kampman","year":"2008","journal-title":"Neuroepidemiology"},{"key":"key-10.4103\/2213-879X.257879-18","first-page":"1220","volume-title":"Association of Vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","author":"Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-19","first-page":"193","volume-title":", Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis","author":"Simpson","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2213-879X.257879-20","first-page":"618","volume-title":"Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis","author":"Mowry","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2213-879X.257879-21","first-page":"288","volume-title":"The Vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of Vitamin D in multiple sclerosis","author":"Bhargava","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"key-10.4103\/2213-879X.257879-22","first-page":"187","volume-title":"Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after Vitamin D supplementation","author":"Pierrot-Deseilligny","year":"2012","journal-title":"Ther Adv Neurol Disord"},{"key":"key-10.4103\/2213-879X.257879-23","first-page":"471","volume-title":"Outdoor activities and diet in childhood and adolescence relate to MS risk above the arctic circle","author":"Kampman","year":"2007","journal-title":"J Neurol"},{"key":"key-10.4103\/2213-879X.257879-24","first-page":"965","volume-title":"The consequences of UV-induced immunosuppression for human health","author":"Norval","year":"2011","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/2213-879X.257879-25","first-page":"75","volume-title":"UV light selectively inhibits spinal cord inflammation and demyelination in experimental autoimmune encephalomyelitis","author":"Wang","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"key-10.4103\/2213-879X.257879-26","first-page":"6418","volume-title":"UV radiation suppresses experimental autoimmune encephalomyelitis independent of Vitamin D production","author":"Becklund","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2213-879X.257879-27","first-page":"44","volume-title":"Efficacy of Vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon \u03b2-1a: A phase II, multicenter, double-blind, randomized, placebo-controlled trial","author":"Smolders","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/2213-879X.257879-28","first-page":"271","volume-title":"Monthly ambient sunlight, infections and relapse rates in multiple sclerosis","author":"Tremlett","year":"2008","journal-title":"Neuroepidemiology"},{"key":"key-10.4103\/2213-879X.257879-29","first-page":"199","volume-title":"Multiple sclerosis relapses: Epidemiology, outcomes and management.A systematic review","author":"Kalincik","year":"2015","journal-title":"Neuroepidemiology"},{"key":"key-10.4103\/2213-879X.257879-30","first-page":"1132","volume-title":", Blizzard L, Otahal P, Van der Mei I, Taylor B.Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis","author":"Simpson","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/2213-879X.257879-31","first-page":"2207","volume-title":"Risk factors for increased multiple sclerosis susceptibility in the Iranian population","author":"Mansouri","year":"2014","journal-title":"J Clin Neurosci"},{"key":"key-10.4103\/2213-879X.257879-32","first-page":"1042","volume-title":"Sun exposure and multiple sclerosis risk in Norway and Italy: The envIMS study","author":"Bj\u00f8rnevik","year":"2014","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-33","first-page":"540","volume-title":"Sun exposure and Vitamin D are independent risk factors for CNS demyelination","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"key-10.4103\/2213-879X.257879-34","first-page":"198","volume-title":"Management of women with multiple sclerosis through pregnancy and after childbirth","author":"Coyle","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"key":"key-10.4103\/2213-879X.257879-35","first-page":"207","volume-title":"Fertility, pregnancy and childbirth in patients with multiple sclerosis: Impact of disease-modifying drugs","author":"Amato","year":"2015","journal-title":"CNS Drugs"},{"key":"key-10.4103\/2213-879X.257879-36","first-page":"537","volume-title":"Multiple sclerosis and motherhood choice: An observational study in Portuguese women patients","author":"Carvalho","year":"2014","journal-title":"Rev Neurol"},{"key":"key-10.4103\/2213-879X.257879-37","first-page":"47","volume-title":"Gender effects in relapsing-remitting multiple sclerosis: Correlation between clinical variables and gene expression molecular pathways","author":"Achiron","year":"2009","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/2213-879X.257879-38","first-page":"1170","volume-title":"Low Vitamin D and elevated immunoreactivity against Epstein\u2013Barr virus before first clinical manifestation of multiple sclerosis","author":"D\u00e9card","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/2213-879X.257879-39","first-page":"239","volume-title":"Estrogen and testosterone therapies in multiple sclerosis","author":"Gold","year":"2009","journal-title":"Prog Brain Res"},{"key":"key-10.4103\/2213-879X.257879-40","first-page":"237","volume-title":"Sex and gender issues in multiple sclerosis","author":"Harbo","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"key-10.4103\/2213-879X.257879-41","first-page":"682","volume-title":"Increase in multiple sclerosis activity after assisted reproduction technology","author":"Correale","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2213-879X.257879-42","first-page":"1310","volume-title":"Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis","author":"MacKenzie-Graham","year":"2012","journal-title":"J Neurosci Res"},{"key":"key-10.4103\/2213-879X.257879-43","doi-asserted-by":"crossref","unstructured":"Finkelsztejn A, Brooks JB, Paschoal FM Jr., Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011;118:790-7.","DOI":"10.1111\/j.1471-0528.2011.02931.x"},{"key":"key-10.4103\/2213-879X.257879-44","first-page":"255","volume-title":"Sex-related factors in multiple sclerosis susceptibility and progression","author":"Voskuhl","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"key-10.4103\/2213-879X.257879-45","first-page":"38","volume-title":"Long-term effects of childbirth in MS","author":"D'hooghe","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/2213-879X.257879-46","first-page":"54","volume-title":"Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis","author":"Gorman","year":"2009","journal-title":"Arch Neurol"},{"key":"key-10.4103\/2213-879X.257879-47","first-page":"97","volume-title":"Treatment of acute relapses in multiple sclerosis","author":"Berkovich","year":"2013","journal-title":"Neurotherapeutics"},{"key":"key-10.4103\/2213-879X.257879-48","first-page":"1313","volume-title":"Clinical viral infections and multiple sclerosis","author":"Sibley","year":"1985","journal-title":"Lancet"},{"key":"key-10.4103\/2213-879X.257879-49","first-page":"958","volume-title":"Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis","author":"Langer-Gould","year":"2009","journal-title":"Arch Neurol"},{"key":"key-10.4103\/2213-879X.257879-50","first-page":"165","volume-title":"Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: The Italian cohort study","author":"Past\u00f2","year":"2012","journal-title":"BMC Neurol"},{"key":"key-10.4103\/2213-879X.257879-51","first-page":"157","volume-title":"Treatment optimization in multiple sclerosis","author":"Freedman","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"key-10.4103\/2213-879X.257879-52","first-page":"344","volume-title":"Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients","author":"R\u00edo","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2213-879X.257879-53","first-page":"954","volume-title":"Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: Evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP study)","author":"Clerico","year":"2014","journal-title":"JAMA Neurol"},{"key":"key-10.4103\/2213-879X.257879-54","first-page":"867","volume-title":"Offspring number, pregnancy, and risk of a first clinical demyelinating event: The ausImmune study","author":"Ponsonby","year":"2012","journal-title":"Neurology"},{"key":"key-10.4103\/2213-879X.257879-55","first-page":"546","volume-title":"Reproductive history and risk of multiple sclerosis","author":"Nielsen","year":"2011","journal-title":"Epidemiology"},{"key":"key-10.4103\/2213-879X.257879-56","first-page":"864","volume-title":", Charlesworth JC, Mei IV, Waubant E, et al. Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis","author":"Zhou","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/2213-879X.257879-57","doi-asserted-by":"crossref","unstructured":"Didonna A, Oksenberg JR. The genetics of multiple sclerosis. In: Zagon IS, McLaughlin PJ, editors. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. Brisbane (AU): Codon Publications; 2017.","DOI":"10.15586\/codon.multiplesclerosis.2017.ch1"},{"key":"key-10.4103\/2213-879X.257879-58","first-page":"271","volume-title":"Epstein\u2013Barr virus infection and multiple sclerosis: A review","author":"Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"key-10.4103\/2213-879X.257879-59","first-page":"817238","volume-title":"Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: A systematic review","author":"McKay","year":"2015","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/2213-879X.257879-60","first-page":"600","volume-title":"The effect of gender in clinically isolated syndrome (CIS): A meta-analysis","author":"Dobson","year":"2012","journal-title":"Mult Scler"},{"key":"key-10.4103\/2213-879X.257879-61","first-page":"1061","volume-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","author":"Mowry","year":"2009","journal-title":"J Neurol"}],"container-title":["Journal of Microscopy and Ultrastructure"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T04:58:45Z","timestamp":1567141125000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jmau.org\/text.asp?2019\/7\/3\/103\/257879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["257879"],"URL":"https:\/\/doi.org\/10.4103\/jmau.jmau_59_18","relation":{},"ISSN":["2213-879X"],"issn-type":[{"value":"2213-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}